Cystitis medical therapy

Jump to navigation Jump to search
Urinary Tract Infections Main Page

Cystitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cystitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultarsound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Tests

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cystitis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cystitis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cystitis medical therapy

CDC on Cystitis medical therapy

Cystitis medical therapy in the news

Blogs on Cystitis medical therapy

Directions to Hospitals Treating Cystitis

Risk calculators and risk factors for Cystitis medical therapy

Steven C. Campbell, M.D., Ph.D.

Overview

Because of the risk of the infection spreading to the kidneys (complicated UTI) and due to the high complication rate in the elderly population and in diabetics, prompt treatment is almost always recommended.

Medical Therapy

The decision to use antimicrobials should be case by case, in other word it should depend on the patients specifics like allergy and compliance history, availability and cost of treatment and resistant rates at the local community.

Uncomplicated cyctitis

Acute uncomplicated cystitis definition includes Premenopausal, nonpregnant women with no known urological abnormalities or comorbidities,postmenopausal women or well-controlled diabetes female patients.[1]


Acute Bacterial Uncomplicated Cystitis†
Preferred Regimen
Nitrofurantoin 100 mg po q12h×5 days
OR
TMP-SMX‡ 1 DS tab po q12h×3 days
OR
Fosfomycin 3 gm single dose
OR
Pivmecillinam♦ 400 mg bid×5 days
Alternative Regimen
Fluoroquinolones for 3 days
Ofloxacin 200–400 mg po bid.
Ciprofloxacin 250 mg bid po or Cipro XR 500 mg q24h
Levofloxacin 250–750 mg po q24

OR
β-lactam agents for 3-7 days
Amoxicillin-clavulanate 500/125 mg po tid or 875/125 mg po bid
Cefdinir 300 mg po q12h or 600 mg po q24
Cefaclor 250-500 mg po q8h
Cefpodoxime-proxetil 100-200 mg po q12h

Others(Cephalexin250-500 mg po q6h ) not studied well but effective.

‡Avoid if resistance prevalence is known to exceed 20% or if used for UTI in previous 3 months.Pivmecillinam is available in some European countries, not licensed in US.

  • Being the most common cause of cystitis(75-90%), E.Coli susceptibility should be considered to choose the appropriate empirical antimicrobial.Other organisms like Proteus mirabilis, Klebsiella pneumoniae and Staphylococcus saprophyticus are far less common.
  • TMP-SMX is preferred to use in areas where the resistance rates are less than 20%.[8][9]
  • Nitrofurantoin, fosfomycin and mecillinam shouldn't be used when pyelonephritis is suspected, because they have weak penetration to the renal tissue.
  • Use of broad-spectrum antimicrobials resulted multidrug resistant organisms,[10]so they are used as alternative to the first line drugs in case of allergy, unavailability or intolerance.[11][12]
  • Beta-lactams have less efficacy than fluoroquinolones.[13][14]
  • Post-therapy urine culture is recommended only for pregnant women[15], multiple early recurrences with the same strain of bacteria and for persistent hematuria.

Complicated cyctitis

All men considered as complicated infection, others include pregnant women and children with metabolic or anatomical abnoramlities, as a general rule all patients with risk of serious complications and/or failure of treatment(stones, obstruction, immunocompromised patients, neurogenic bladder, renal failure,transplant patients) considered as complicated infections.Hooton, TM. (2012). "Clinical practice. Uncomplicated urinary tract infection". N Engl J Med. 366 (11): 1028–37. doi:10.1056/NEJMcp1104429. PMID 22417256. Unknown parameter |month= ignored (help)


Complicated cyctitis
Regimen
Fluoroquinolones for ≥7 days
Ofloxacin 200–400 mg po bid.
Ciprofloxacin 250 mg bid po or Cipro XR 500 mg q24h
Levofloxacin 250–750 mg po q24.

References

  1. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG; et al. (2011). "International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases". Clin Infect Dis. 52 (5): e103–20. doi:10.1093/cid/ciq257. PMID 21292654.
  2. Kahlmeter, G. (2003). "An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project". J Antimicrob Chemother. 51 (1): 69–76. PMID 12493789. Unknown parameter |month= ignored (help)
  3. Naber, KG.; Schito, G.; Botto, H.; Palou, J.; Mazzei, T. (2008). "Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy". Eur Urol. 54 (5): 1164–75. doi:10.1016/j.eururo.2008.05.010. PMID 18511178. Unknown parameter |month= ignored (help)
  4. Gupta, K.; Hooton, TM.; Roberts, PL.; Stamm, WE. (2007). "Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women". Arch Intern Med. 167 (20): 2207–12. doi:10.1001/archinte.167.20.2207. PMID 17998493. Unknown parameter |month= ignored (help)
  5. Iravani, A.; Klimberg, I.; Briefer, C.; Munera, C.; Kowalsky, SF.; Echols, RM. (1999). "A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection". J Antimicrob Chemother. 43 Suppl A: 67–75. PMID 10225575. Unknown parameter |month= ignored (help)
  6. Stein, GE. (1999). "Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection". Clin Ther. 21 (11): 1864–72. doi:10.1016/S0149-2918(00)86734-X. PMID 10890258. Unknown parameter |month= ignored (help)
  7. Minassian, MA.; Lewis, DA.; Chattopadhyay, D.; Bovill, B.; Duckworth, GJ.; Williams, JD. (1998). "A comparison between single-dose fosfomycin trometamol (Monuril) and a 5-day course of trimethoprim in the treatment of uncomplicated lower urinary tract infection in women". Int J Antimicrob Agents. 10 (1): 39–47. PMID 9624542. Unknown parameter |month= ignored (help)
  8. Gupta, K. (2003). "Emerging antibiotic resistance in urinary tract pathogens". Infect Dis Clin North Am. 17 (2): 243–59. PMID 12848469. Unknown parameter |month= ignored (help)
  9. Raz, R.; Chazan, B.; Kennes, Y.; Colodner, R.; Rottensterich, E.; Dan, M.; Lavi, I.; Stamm, W. (2002). "Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens". Clin Infect Dis. 34 (9): 1165–9. doi:10.1086/339812. PMID 11941541. Unknown parameter |month= ignored (help)
  10. Hooton, TM.; Besser, R.; Foxman, B.; Fritsche, TR.; Nicolle, LE. (2004). "Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy". Clin Infect Dis. 39 (1): 75–80. doi:10.1086/422145. PMID 15206056. Unknown parameter |month= ignored (help)
  11. Paterson, DL. (2004). "Collateral damage from cephalosporin or quinolone antibiotic therapy". Clin Infect Dis. 38 Suppl 4: S341–5. doi:10.1086/382690. PMID 15127367. Unknown parameter |month= ignored (help)
  12. Ramphal, R.; Ambrose, PG. (2006). "Extended-spectrum beta-lactamases and clinical outcomes: current data". Clin Infect Dis. 42 Suppl 4: S164–72. doi:10.1086/500663. PMID 16544267. Unknown parameter |month= ignored (help)
  13. Rodríguez-Baño, J.; Alcalá, JC.; Cisneros, JM.; Grill, F.; Oliver, A.; Horcajada, JP.; Tórtola, T.; Mirelis, B.; Navarro, G. (2008). "Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli". Arch Intern Med. 168 (17): 1897–902. doi:10.1001/archinte.168.17.1897. PMID 18809817. Unknown parameter |month= ignored (help)
  14. Hooton, TM.; Scholes, D.; Gupta, K.; Stapleton, AE.; Roberts, PL.; Stamm, WE. (2005). "Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial". JAMA. 293 (8): 949–55. doi:10.1001/jama.293.8.949. PMID 15728165. Unknown parameter |month= ignored (help)
  15. Nicolle, LE.; Bradley, S.; Colgan, R.; Rice, JC.; Schaeffer, A.; Hooton, TM. (2005). "Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults". Clin Infect Dis. 40 (5): 643–54. doi:10.1086/427507. PMID 15714408. Unknown parameter |month= ignored (help)

Template:WikiDoc Sources